Mass drug administration (MDA) of antibiotics to all children in a community or population has the potential to reduce infectious diseases and reduce childhood mortality globally. However, MDA requires weighing near-term gains against longer-term risks of antibiotic resistance, which would impair treatment of serious bacterial infections; fairly distributing benefits and risks among individuals, communities, and whole societies; obtaining informed consent, and engaging the community.
Our Grants
Mass Administration of Antibiotics: Reaching Clinical and Community Equipoise
Anthony Deh-Chuen So, MD, MPA
Johns Hopkins University
Johns Hopkins University
Grant Type
Making a Difference
Grant Cycle
spring 2020
Duration
12 Months
Amount
$128,857
-
Nelson K. Sewankambo & Paul Kutyabami, Empowering local research ethics review of antibacterial mass administration research, BioMed Central, Sept 2022
Read more -
Ahmed Alasmar, Alex C. Kong, Anthony D. So & Matthew DeCamp, Ethical challenges in mass drug administration for reducing childhood mortality: a qualitative study, BioMed Central, Sept 2022
Read more -
Anthony So and Matthew DeCamp, Mass Drug Administration of Antibiotics: Reaching Clinical and Community Equipoise, BioMed Central, June 2022
Read more
Grant Focus Areas
Share